000 01618 a2200445 4500
005 20250515064435.0
264 0 _c20070628
008 200706s 0 0 eng d
022 _a0926-9959
024 7 _a10.1111/j.1468-3083.2006.01923.x
_2doi
040 _aNLM
_beng
_cNLM
100 1 _ade Moraes, A P
245 0 0 _aAn open-label efficacy pilot study with pimecrolimus cream 1% in adults with facial seborrhoeic dermatitis infected with HIV.
_h[electronic resource]
260 _bJournal of the European Academy of Dermatology and Venereology : JEADV
_cMay 2007
300 _a596-601 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAdministration, Topical
650 0 4 _aAdult
650 0 4 _aDermatitis, Seborrheic
_xcomplications
650 0 4 _aDermatologic Agents
_xadministration & dosage
650 0 4 _aFacial Dermatoses
_xcomplications
650 0 4 _aFemale
650 0 4 _aHIV Infections
_xcomplications
650 0 4 _aHumans
650 0 4 _aMale
650 0 4 _aMiddle Aged
650 0 4 _aOintments
650 0 4 _aPilot Projects
650 0 4 _aRecurrence
650 0 4 _aTacrolimus
_xadministration & dosage
650 0 4 _aTreatment Outcome
700 1 _ade Arruda, E A G
700 1 _aVitoriano, M A V
700 1 _ade Moraes Filho, M O
700 1 _aBezerra, F A F
700 1 _ade Magalhães Holanda, E
700 1 _ade Moraes, M E A
773 0 _tJournal of the European Academy of Dermatology and Venereology : JEADV
_gvol. 21
_gno. 5
_gp. 596-601
856 4 0 _uhttps://doi.org/10.1111/j.1468-3083.2006.01923.x
_zAvailable from publisher's website
999 _c16997741
_d16997741